| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 582.63B | 602.38B | 578.60B | 518.38B | 483.99B | 470.38B |
| Gross Profit | 85.39B | 93.01B | 81.06B | 59.13B | 58.00B | 64.30B |
| EBITDA | 41.64B | 48.45B | 41.74B | 28.09B | 31.26B | 40.18B |
| Net Income | 15.13B | 23.28B | 17.18B | 12.54B | 14.78B | 25.16B |
Balance Sheet | ||||||
| Total Assets | 474.13B | 573.39B | 537.74B | 519.96B | 436.75B | 435.79B |
| Cash, Cash Equivalents and Short-Term Investments | 58.82B | 59.84B | 53.48B | 50.04B | 32.48B | 50.93B |
| Total Debt | 89.53B | 134.85B | 127.49B | 117.09B | 61.11B | 59.98B |
| Total Liabilities | 211.56B | 284.94B | 267.86B | 259.87B | 182.45B | 186.54B |
| Stockholders Equity | 254.32B | 279.44B | 261.50B | 251.98B | 246.82B | 242.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 15.48B | 12.36B | 27.62B | -280.00M | 4.38B |
| Operating Cash Flow | 0.00 | 24.08B | 18.05B | 33.63B | 5.32B | 12.97B |
| Investing Cash Flow | 0.00 | -11.20B | -9.37B | -55.55B | -12.31B | -46.20B |
| Financing Cash Flow | 0.00 | -6.73B | -6.41B | 38.82B | -12.57B | 38.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥659.28B | 15.99 | 8.34% | 2.66% | 2.61% | 22.78% | |
78 Outperform | ¥265.36B | 9.89 | 7.43% | 2.78% | 2.69% | -6.90% | |
78 Outperform | ¥1.40T | 17.13 | 14.94% | 2.00% | 10.44% | 50.36% | |
78 Outperform | ¥661.42B | 11.33 | ― | 2.15% | 0.46% | 38.67% | |
72 Outperform | ¥578.94B | 14.38 | ― | 2.51% | 17.43% | 16.94% | |
70 Neutral | ¥335.38B | 13.64 | 8.70% | 2.28% | 4.11% | 37.43% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |